UBS Group

UBS Group’s Nuveen AA-BBB CLO ETF NCLO Stock Holding History

UBS Group’s Portfolio NCLO Stock Details NCLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-432	Closed	-$10.8K	–	11417
2025 Q3	$10.8K	Sell	432 -2,547	-85%	-$63.8K	﹤0.01%	8514
2025 Q2	$74.8K	Buy	+2,979	New	+$74.4K	﹤0.01%	7461

Other funds holding NCLO

Diversified Portfolios Inc Bloomfield Hills, Michigan $1.38B AUM 14.49% 1-Year Est. Return

Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return

Corrado Advisors Ramsey, New Jersey $217M AUM 26.96% 1-Year Est. Return

Thompson David Blair $200M AUM

GC Wealth Management RIA Cambridge, Massachusetts $1.73B AUM 16.14% 1-Year Est. Return

Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return

Sunbelt Securities Houston, Texas $1.58B AUM 28.96% 1-Year Est. Return

Flagstar Advisors New York $331M AUM 40.98% 1-Year Est. Return

Trajan Wealth Scottsdale, Arizona $2.65B AUM 17.06% 1-Year Est. Return

Closed-End Fund Advisors Richmond, Virginia $102M AUM

UBS Group's NCLO Position: Q4 2025 in Review

UBS Group sold out of Nuveen AA-BBB CLO ETF (NCLO) in Q4 2025, closing a stake of 432 shares — an estimated $10.8K sold.

UBS Group first reported a position in NCLO in Q2 2025 and held it in 2 quarters. The position peaked at $74.8K in Q2 2025. 12 funds tracked by Wall St. Rank hold NCLO as of Q4 2025.

UBS Group reported no remaining Nuveen AA-BBB CLO ETF position as of Q4 2025 after selling out during the quarter.
UBS Group sold 432 Nuveen AA-BBB CLO ETF shares in Q4 2025, an estimated $10.8K.
UBS Group first reported a position in Nuveen AA-BBB CLO ETF in Q2 2025 and held it in 2 quarters.
UBS Group's Nuveen AA-BBB CLO ETF position peaked at $74.8K in Q2 2025.
12 funds tracked by Wall St. Rank held Nuveen AA-BBB CLO ETF as of Q4 2025.

Based on UBS Group's 13F filing for Q4 2025, filed 29 Jan 2026.